Pharmaniaga

Pharmaniaga Berhad is a Malaysian integrated pharmaceutical group. The ambit of their business interests ranges from warehousing and distribution of pharmaceutical and medical products, manufacturing of generic pharmaceuticals, marketing and sales; research and development; trading and installation of medical and hospital equipment as well as community pharmacy.

Pharmaniaga Berhad
Public
Traded asMYX: 7081
Industry
PredecessorRemedi Pharmaceuticals (1994-1998)[1]
Founded1994 (1994)
HeadquartersShah Alam, Selangor, Malaysia
Area served
Worldwide
Key people
Farshila Emran (Managing Director)
ProductsPrescription drugs, over-the-counter drugs, biopharmaceuticals
Revenue RM1.2 billion (2018)[2]
RM15.05 billion (Q3 2018)[3]
Number of employees
3,322
ParentBoustead Holdings
Websitewww.pharmaniaga.com

As an entity listed on the Main Board of Bursa Malaysia Securities Berhad with a strong domestic presence, the company is steadily growing their business presence through their expansion initiatives.[4]

History

Pharmaniaga was established in 1994 as Remedi Pharmaceuticals.[1] The company was renamed as Pharmaniaga in August 1998 and is the first healthcare company in Malaysia to be listed in the Main Market of Kuala Lumpur Stock Exchange (now Bursa Malaysia).[5]

Ownership

Pharmaniaga is a public limited company. As at 29 May 2020, Boustead Holdings owns 55.93% of the company, while Lembaga Tabung Angkatan Tentera (LTAT) owns 11.12%. The major owner of Boustead Holdings is itself LTAT.

As at 21 May 2020, the Board of Directors of Pharmaniaga are Datuk (Dr.) Hafsah Hashim who serves as the Independent Non-Executive Chairman and Mohamed Iqbal Abdul Rahman as the Acting Group Managing Director. The company's Independent Non-Executive Directors are Lieutenant General Dato' Seri Panglima Dr. Sulaiman Abdullah (Retired), Brigadier General Dato' Mohd Shahrom Mohamad (RTD.), Dato' Mohd Zahir Zahur Hussain and Dr. Salmah Bahri. While the Non-Independent Non-Executive Director is Datuk Koo Hock Fee.[6]

References
  1. Malaysia’s Top 10 pharmaceutical companies Top10malaysia (August 26, 2015). Retrieved on August 26, 2015.
  2. Mohd Shahizam Tazali (10 August 2018). Pharmaniaga catat hasil RM1.2 bilion Utusan Malaysia. Retrieved on 12 January 2019.
  3. Emir Zainul (19 November 2018). Pharmaniaga, Paramount, AirAsia, RHB, MRCB, CIMB, MISC, Deleum, SunCon, DNex, Ni Hsin and MMAG The Edge Markets. Retrieved on January 12, 2019.
  4. "Pharmaniaga Berhad Annual Report 2018" (PDF).
  5. Pharmaniaga Berhad: An analysis UK Essay (April 5, 2017). Retrieved on April 5, 2017.
  6. "NST".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.